Your browser doesn't support javascript.
loading
Venetoclax and dinaciclib elicit synergistic preclinical efficacy against hypodiploid acute lymphoblastic leukemia.
Pariury, Holly; Fandel, Joshua; Bachl, Stefanie; Ang, Kenny K; Markossian, Sarine; Wilson, Chris G; Braun, Benjamin S; Popescu, Bogdan; Wohlfeil, Margo; Beckman, Kyle; Xirenayi, Simayijiang; Roy, Ritu P; Olshen, Adam B; Smith, Catherine; Arkin, Michelle R; Loh, Mignon L; Diaz-Flores, Ernesto.
Affiliation
  • Pariury H; Department of Pediatrics, Benioff Children's Hospital, and the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco; CA; Department of Pediatrics, Banner University Medical Center and the University of Arizona Cancer Center, Tucson; AZ.
  • Fandel J; Department of Pediatrics, Benioff Children's Hospital, and the Helen Diller Family Comprehensive Cancer Center, University of California.
  • Bachl S; Department of Pediatrics, Benioff Children's Hospital, and the Helen Diller Family Comprehensive Cancer Center, University of California.
  • Ang KK; Small Molecule Discovery Center, Department of Pharmaceutical Chemistry, University of California.
  • Markossian S; Small Molecule Discovery Center, Department of Pharmaceutical Chemistry, University of California.
  • Wilson CG; Small Molecule Discovery Center, Department of Pharmaceutical Chemistry, University of California.
  • Braun BS; Department of Pediatrics, Benioff Children's Hospital, and the Helen Diller Family Comprehensive Cancer Center, University of California.
  • Popescu B; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco.
  • Wohlfeil M; Department of Pediatrics, Benioff Children's Hospital, and the Helen Diller Family Comprehensive Cancer Center, University of California.
  • Beckman K; Department of Pediatrics, Benioff Children's Hospital, and the Helen Diller Family Comprehensive Cancer Center, University of California.
  • Xirenayi S; Department of Pediatrics, Benioff Children's Hospital, and the Helen Diller Family Comprehensive Cancer Center, University of California.
  • Roy RP; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco.
  • Olshen AB; Computation Biology and Informatics Core at the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco; CA; Department of Epidemiology and Biostatistics, University of California.
  • Smith C; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco.
  • Arkin MR; Small Molecule Discovery Center, Department of Pharmaceutical Chemistry, University of California.
  • Loh ML; Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute; Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA.
  • Diaz-Flores E; Department of Pediatrics, Benioff Children's Hospital, and the Helen Diller Family Comprehensive Cancer Center, University of California. ernesto.diaz-flores@ucsf.edu.
Haematologica ; 108(5): 1272-1283, 2023 05 01.
Article in En | MEDLINE | ID: mdl-36700399
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Precursor Cell Lymphoblastic Leukemia-Lymphoma / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Haematologica Year: 2023 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Precursor Cell Lymphoblastic Leukemia-Lymphoma / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Haematologica Year: 2023 Document type: Article Country of publication: